Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer by Sharma, Priyanka, Abramson, Vandana G, O'Dea, Anne, Nye, Lauren, Mayer, Ingrid, Pathak, Harsh B, Hoffmann, Marc, Stecklein, Shane R, Elia, Manana, Lewis, Sharon, Scott, Jecinta, De Jong, Jilliann A, Wang, Yen Y, Yoder, Rachel, Schwensen, Kelsey, Finke, Karissa, Heldstab, Jaimie, LaFaver, Stephanie, Williamson, Stephen K, Phadnis, Milind A, Reed, Gregory A, Kimler, Bruce F, Khan, Qamar J, Godwin, Andrew K

Get full text

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer by Yoder, Rachel, Kimler, Bruce F., Staley, Joshua M., Schwensen, Kelsey, Wang, Yen Y., Finke, Karissa, O’Dea, Anne, Nye, Lauren, Elia, Manana, Crane, Gregory, McKittrick, Richard, Pluenneke, Robert, Madhusudhana, Sheshadri, Beck, Larry, Shrestha, Anuj, Corum, Larry, Marsico, Mark, Stecklein, Shane R., Godwin, Andrew K., Khan, Qamar J., Sharma, Priyanka

Get full text

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease by Stecklein, Shane R., Kimler, Bruce F., Yoder, Rachel, Schwensen, Kelsey, Staley, Joshua M., Khan, Qamar J., O’Dea, Anne P., Nye, Lauren E., Elia, Manana, Heldstab, Jaimie, Home, Trisha, Hyter, Stephen, Isakova, Kamilla, Pathak, Harsh B., Godwin, Andrew K., Sharma, Priyanka

Get full text

Abstract P2-13-34: A phase II trial of lapatinib and everolimus for HER2 positive metastatic breast cancer by Rooney, Anthony, Sharma, Priyanka, O'Dea, Anne P, Nye, Lauren, Elia, Manana, He, Jianghua, Fabian, Carol, Khan, Qamar

Get full text

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP) by Sharma, Priyanka, Kimler, Bruce F, O'Dea, Anne, Nye, Lauren, Wang, Yen Y, Yoder, Rachel, Staley, Joshua M, Prochaska, Lindsey, Wagner, Jamie, Amin, Amanda L, Larson, Kelsey, Balanoff, Christa, Elia, Manana, Crane, Gregory, Madhusudhana, Sheshadri, Hoffmann, Marc, Sheehan, Maureen, Rodriguez, Roberto, Finke, Karissa, Shah, Rajvi, Satelli, Deepti, Shrestha, Anuj, Beck, Larry, McKittrick, Richard, Pluenneke, Robert, Raja, Vinay, Beeki, Venkatadri, Corum, Larry, Heldstab, Jaimie, LaFaver, Stephanie, Prager, Micki, Phadnis, Milind, Mudaranthakam, Dinesh Pal, Jensen, Roy A, Godwin, Andrew K, Salgado, Roberto, Mehta, Kathan, Khan, Qamar

Get full text

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing by Sharma, Priyanka, Klemp, Jennifer R., Kimler, Bruce F., Mahnken, Jonathan D., Geier, Larry J., Khan, Qamar J., Elia, Manana, Connor, Carol S., McGinness, Marilee K., Mammen, Joshua M. W., Wagner, Jamie L., Ward, Claire, Ranallo, Lori, Knight, Catherine J., Stecklein, Shane R., Jensen, Roy A., Fabian, Carol J., Godwin, Andrew K.

Get full text

Abstract P2-01-05: Impact of post-treatment ctDNA and residual cancer burden (RCB) on outcomes in patients with triple-negative breast cancer (TNBC) and residual disease by Sharma, Priyanka, Stecklein, Shane R, Kimler, Bruce F, Yoder, Rachel, Schwensen, Kelsey, Staley, Joshua M, Khan, Qamar J, O'Dea, Anne P, Nye, Lauren E, Elia, Manana, Heldstab, Jaimie, Home, Trisha, Hyter, Stephen, Isakova, Kamilla, Pathak, Harsh B, Godwin, Andrew K

Get full text

Abstract PS6-04: Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2 negative breast cancer by Yoder, Rachel, Kimler, Bruce F, Staley, Joshua M, Schwensen, Kelsey, Wang, Yen Y, Finke, Karissa, O'Dea, Anne, Nye, Lauren, Elia, Manana, Crane, Gregory, McKittrick, Richard, Pluenneke, Robert, Madhusudhana, Sheshadri, Beck, Larry, Rodriguez, Roberto, Shrestha, Anuj, Corum, Larry, Marsico, Mark, Godwin, Andrew K, Khan, Qamar, Sharma, Priyanka

Get full text

Abstract PD1-06: Black patients with triple negative breast cancer (TNBC) have enriched stromal tumor infiltrating lymphocytes (sTILs) and receive preferential benefit from neoadju... by Stecklein, Shane R., Yoder, Rachel, Salgado, Roberto, Staley, Joshua M., O’Dea, Anne, Nye, Lauren, Elia, Manana, Satelli, Deepti, Crane, Gregory, McKittrick, Richard, Godwin, Andrew K., Khan, Qamar, Sharma, Priyanka

Get full text

Abstract PD11-07: PD11-07 Association of TNBC-DX scores with outcomes in triple-negative breast cancer (TNBC) treated with neoadjuvant pembrolizumab and chemotherapy: a correlative... by Sharma, Priyanka, Stecklein, Shane R., Yoder, Rachel, Staley, Joshua M., Salgado, Roberto, Paré, Laia, Conte, Benedetta, Brasó-Maristany, Fara, O’Dea, Anne, Nye, Lauren, Elia, Manana, Satelli, Deepti, Crane, Gregory, McKittrick, Richard, Khan, Qamar, Godwin, Andrew K., Prat, Aleix

Get full text

Selenium species determination in foods harvested in Seleniferous soils by HPLC-ICP-MS after enzymatic hydrolysis assisted by pressurization and microwave energy by Moreda-Piñeiro, Jorge, Sánchez-Piñero, Joel, Mañana-López, Adriana, Turnes-Carou, Isabel, Alonso-Rodríguez, Elia, López-Mahía, Purificación, Muniategui-Lorenzo, Soledad

Get full text

Multi-element determinations in foods from Amazon region by ICP-MS after enzymatic hydrolysis assisted by pressurisation and microwave energy by Moreda-Piñeiro, Jorge, Sánchez-Piñero, Joel, Mañana-López, Adriana, Turnes-Carou, Isabel, Alonso-Rodríguez, Elia, López-Mahía, Purificación, Muniategui-Lorenzo, Soledad

Get full text